pharmacy benefit manager
-
What CVS Stands to Gain by Setting Up Biosimilar Subsidiary Cordavis
Pharmaceutical industry observers say CVS Health’s creation of Cordavis, a new biosimilar drugs company, is part of a strategy to make its move into this market as profitable as possible.
-
MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Danny Sanchez, CEO of EmpiRx Health
In this month’s episode, we dive into some of the recent executive appointments occurring in the healthcare sector, as well as layoffs affecting the industry. We also hear from Danny Sanchez, who recently became the new CEO of EmpiRx Health, a value-based pharmacy benefit manager.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Consumer / Employer, Health Tech, Pharma
Medicare Drug Negotiation Is the Model for the Future of Drug Pricing, Abarca CEO Says
For the first time ever, CMS is preparing to negotiate prices for drugs paid for by Medicare. This has sparked a huge debate — will the creation of this taxpayer-funded drug negotiation infrastructure be a failed experiment, or will it become the standard for the future of drug pricing in this country? Jason Borschow, president and CEO of Abarca Health, says it’s the latter.
-
Consumer / Employer, Health Tech, Hospitals
Is Interoperability Tech Worth the Investment? Experts Say Yes for 3 Reasons
Panelists at a recent healthcare conference expressed optimism about the automation technology that health plans, pharmacy benefit managers and providers can adopt to facilitate real-time data sharing. They said that such technology has potential to improve medication adherence, reduce costs and save time for both providers and payers.
-
Mark Cuban’s Cost Plus Drugs Turns Focus to Employers
Through the partnership, the organizations are launching EmsanaRx Plus. The product supplements employers’ current pharmacy benefit offerings and provides access to Cost Plus Drugs’ discounted medications.
-
Express Scripts Must Pay State AG $3.2M for Allegedly Overcharging for Prescriptions
Following an investigation, the AG claimed Express Scripts, “billed and obtained payment for prescription drugs from payers of workers’ compensation claims in excess of amounts permitted by Massachusetts laws and regulations,” according to court documents.
-
With PBM satisfaction on the decline, Centene switches to Express Scripts
Centene is swapping CVS Caremark with Express Scripts. A recent survey that measured benefit leaders’ satisfaction with their PBMs found that Express Scripts performed better than CVS Caremark.
-
States should be allowed to regulate PBMs, according to 35 state AGs advocating in Oklahoma case
A trade association for PBMs says that state PBM regulations in Oklahoma are preempted by federal ERISA and Medicare regulations.
-
Consumer / Employer, Health Tech
PBM WithMe joins health navigation platform Castlight’s partner network
The company touts its personalized approach to helping patients who need the most support with medications, like those who are managing multiple health conditions.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Why the FTC’s recent decision to not study PBMs might hurt consumers and independent pharmacies
With its ruling to maintain the status quo, the FTC has decided to take a back-seat and force independent pharmacies to fend for themselves in their on-going fight to secure access to fair prices that allow them to stay in business and continue to serve their local communities and the well-being of their patients.
-
3 forecasts for the PBM industry in 2022
The current landscape heading into 2022 will keep pharmacy benefits under the microscope. Plan sponsors will evaluate their PBM’s pricing model to determine if their contract will deliver predictable costs, more opportunities for increased savings and improved care for their members.
-
CVS sues pharmacy benefit startup Capital Rx over ‘unenforceable’ non-compete clause
After Capital Rx’s former medical director of pharmacy services got a job offer at CVS, the PBM startup claimed he couldn’t work there because of a noncompete agreement. CVS recently sued the company, saying its non-compete clause was unenforceable.
-
Anthem, Humana join hedge fund administrator to launch technology for PBMs
The hedge fund administrator SS&C Technologies Holdings will be the majority stakeholder, while the two payers will each hold a minority interest in the joint venture, dubbed DomaniRx. The company will develop a claims adjudication platform to support its operations.
-
MedCity Influencers, BioPharma
How real-time pharmacy intelligence can protect against Covid-19 and identify emerging trends
Understanding the medication supply chain, coupled with predictive analytics, will allow hospital pharmacies to be better equipped for any resurgence of the pandemic in their areas.
-
Anthem’s PBM buys pharmacy startup Zipdrug
Anthem’s newly formed PBM, IngenioRx, acquired pharmacy startup Zipdrug. The company facilitates in-home drug delivery and helps health plans track medication adherence.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
